1. Home
  2. HOOK vs SRM Comparison

HOOK vs SRM Comparison

Compare HOOK & SRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOOK
  • SRM
  • Stock Information
  • Founded
  • HOOK 2011
  • SRM 1979
  • Country
  • HOOK United States
  • SRM United States
  • Employees
  • HOOK N/A
  • SRM N/A
  • Industry
  • HOOK Biotechnology: Pharmaceutical Preparations
  • SRM
  • Sector
  • HOOK Health Care
  • SRM
  • Exchange
  • HOOK Nasdaq
  • SRM Nasdaq
  • Market Cap
  • HOOK 9.3M
  • SRM 9.0M
  • IPO Year
  • HOOK 2019
  • SRM 2023
  • Fundamental
  • Price
  • HOOK $1.59
  • SRM $0.58
  • Analyst Decision
  • HOOK Buy
  • SRM
  • Analyst Count
  • HOOK 4
  • SRM 0
  • Target Price
  • HOOK $10.67
  • SRM N/A
  • AVG Volume (30 Days)
  • HOOK 207.3K
  • SRM 473.4K
  • Earning Date
  • HOOK 05-15-2025
  • SRM 05-09-2025
  • Dividend Yield
  • HOOK N/A
  • SRM N/A
  • EPS Growth
  • HOOK N/A
  • SRM N/A
  • EPS
  • HOOK N/A
  • SRM N/A
  • Revenue
  • HOOK $9,351,000.00
  • SRM $4,394,659.00
  • Revenue This Year
  • HOOK N/A
  • SRM N/A
  • Revenue Next Year
  • HOOK N/A
  • SRM N/A
  • P/E Ratio
  • HOOK N/A
  • SRM N/A
  • Revenue Growth
  • HOOK N/A
  • SRM N/A
  • 52 Week Low
  • HOOK $0.72
  • SRM $0.26
  • 52 Week High
  • HOOK $9.09
  • SRM $1.66
  • Technical
  • Relative Strength Index (RSI)
  • HOOK 59.36
  • SRM 64.42
  • Support Level
  • HOOK $1.45
  • SRM $0.55
  • Resistance Level
  • HOOK $1.62
  • SRM $0.66
  • Average True Range (ATR)
  • HOOK 0.16
  • SRM 0.06
  • MACD
  • HOOK -0.00
  • SRM 0.02
  • Stochastic Oscillator
  • HOOK 67.57
  • SRM 67.31

About HOOK HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.

About SRM SRM Entertainment Inc.

SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.

Share on Social Networks: